The epidemiology and economics of chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease responsible for a large human and economic burden around the world. Cigarette smoking is the main risk factor for COPD in the developed world, although other important risk factors include occupational exposures, air pollution, airway hyperresponsiveness, asthma, and genetic predisposition. In most of the world, COPD prevalence and mortality continue to rise in response to increases in smoking, particularly by women and adolescents. COPD is also an important cause of disability, and is linked to comorbid diseases, such as depression and cardiovascular disease, which adds to the large economic burden associated with this disorder. Better public health and medical interventions that target both the risk factors for COPD and look toward earlier intervention may decrease the growing public health impact of COPD.

[1]  A. Phillips,et al.  A Retrospective Analysis of Disability and Its Related Costs Among Employees With Chronic Obstructive Pulmonary Disease , 2007, Journal of occupational and environmental medicine.

[2]  D. Postma,et al.  Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. , 2006, Respiratory research.

[3]  J. Vestbo,et al.  Potential misclassification of causes of death from COPD , 2006, European Respiratory Journal.

[4]  F. Blasi,et al.  Anxiety and depression in COPD patients: The roles of gender and disease severity. , 2006, Respiratory medicine.

[5]  D. Mannino,et al.  Global burden of COPD: systematic review and meta-analysis , 2006, European Respiratory Journal.

[6]  J. Erikssen,et al.  Can global initiative for Chronic Obstructive Lung Disease stage 0 provide prognostic information on long-term mortality in men? , 2006, Chest.

[7]  D. Mannino GOLD stage 0 COPD: is it real? Does it matter? , 2006, Chest.

[8]  D. Górecka,et al.  Smokers with airway obstruction are more likely to quit smoking , 2006, Thorax.

[9]  J. Teeter,et al.  Dissociation of lung function changes with humoral immunity during inhaled human insulin therapy. , 2006, American journal of respiratory and critical care medicine.

[10]  Á. D. de Miguel,et al.  Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study , 2006, Health and quality of life outcomes.

[11]  T. Molen,et al.  Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire , 2006, Respiratory research.

[12]  Rachel Norwood Prevalence and impact of depression in chronic obstructive pulmonary disease patients , 2006, Current opinion in pulmonary medicine.

[13]  R. Perez-Padilla,et al.  Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. , 2006, American journal of respiratory and critical care medicine.

[14]  J. Curtis,et al.  Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. , 2006, Archives of internal medicine.

[15]  J. Samet,et al.  Spirometry for chronic obstructive pulmonary disease case finding in primary care? , 2005, American journal of respiratory and critical care medicine.

[16]  Cesar G Victora,et al.  Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study , 2005, The Lancet.

[17]  A. Hansell,et al.  Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. , 2005, Chest.

[18]  Fernando Holguin,et al.  Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. , 2005, Chest.

[19]  A. Jemal,et al.  Trends in the leading causes of death in the United States, 1970-2002. , 2005, JAMA.

[20]  F. Rutten,et al.  Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. , 2005, European heart journal.

[21]  F. Maltais,et al.  The metabolic syndrome in patients with chronic obstructive pulmonary disease. , 2005, Journal of cardiopulmonary rehabilitation.

[22]  Mark E Kunik,et al.  Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. , 2005, Chest.

[23]  R. Balkissoon,et al.  Current Perspectives on Management of Co-Morbid Depression in COPD , 2005, COPD.

[24]  J. Menzin,et al.  Direct Costs of COPD in the U.S.: An Analysis of Medical Expenditure Panel Survey (MEPS) Data , 2005, COPD.

[25]  P. Dennis Disparities in Cancer Funding , 2004, Science.

[26]  C. Jenkins,et al.  The TORCH (TOwards a Revolution in COPD Health) survival study protocol , 2004, European Respiratory Journal.

[27]  R. Doll,et al.  Mortality in relation to smoking: 50 years' observations on male British doctors , 2004, BMJ : British Medical Journal.

[28]  S Ziebland,et al.  Stigma, shame, and blame experienced by patients with lung cancer: qualitative study , 2004, BMJ : British Medical Journal.

[29]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[30]  V J Carey,et al.  Familial aggregation of FEF25–75 and FEF25–75/FVC in families with severe, early onset COPD , 2004, Thorax.

[31]  D. Mannino,et al.  Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination. , 2003 .

[32]  L. Trupin,et al.  The occupational burden of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[33]  G. Lewith,et al.  Usefulness of GOLD classification of COPD severity , 2003, Thorax.

[34]  B. Celli,et al.  Population impact of different definitions of airway obstruction , 2003, European Respiratory Journal.

[35]  A. Iqbal,et al.  Interpreting COPD prevalence estimates: what is the true burden of disease? , 2003, Chest.

[36]  D. Postma,et al.  Development, validity and responsiveness of the Clinical COPD Questionnaire , 2003, Health and quality of life outcomes.

[37]  E. Silverman,et al.  The genetics of chronic obstructive pulmonary disease , 2001, Respiratory research.

[38]  M. Halpern,et al.  The burden of COPD in the U.S.A.: results from the Confronting COPD survey. , 2003, Respiratory medicine.

[39]  E. Wouters Economic analysis of the Confronting COPD survey: an overview of results. , 2003, Respiratory medicine.

[40]  X. Busquets,et al.  Systemic effects of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[41]  D. Strachan,et al.  Validity and interpretation of mortality, health service and survey data on COPD and asthma in England , 2003, European Respiratory Journal.

[42]  D. Mannino,et al.  Characteristics of adults dying with COPD. , 2002, Chest.

[43]  M. Decramer,et al.  Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey , 2002, European Respiratory Journal.

[44]  L. Trupin,et al.  The influence of chronic respiratory conditions on health status and work disability. , 2002, American journal of public health.

[45]  D. Mannino,et al.  Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. , 2002, Morbidity and mortality weekly report. Surveillance summaries.

[46]  J. Vestbo,et al.  Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? , 2002, American journal of respiratory and critical care medicine.

[47]  A. Schols,et al.  Systemic effects in COPD. , 2002, Chest.

[48]  D. Mannino COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. , 2002, Chest.

[49]  M. Ferrer,et al.  Interpretation of quality of life scores from the St George's Respiratory Questionnaire , 2002, European Respiratory Journal.

[50]  L. Newman,et al.  Genetic and environmental modulation of chronic obstructive pulmonary disease. , 2001, Respiration physiology.

[51]  M. Sullivan,et al.  Health-related quality of life in COPD: why both disease-specific and generic measures should be used. , 2001, The European respiratory journal.

[52]  C. Murray,et al.  Burden of disease--implications for future research. , 2001, JAMA.

[53]  A. Yohannes,et al.  Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire , 2000, International journal of geriatric psychiatry.

[54]  R. Zuwallack,et al.  Functional status and survival following pulmonary rehabilitation. , 2000, Chest.

[55]  T L Petty,et al.  Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. , 2000, Archives of internal medicine.

[56]  S. Ramsey,et al.  The economic burden of COPD. , 2000, Chest.

[57]  V. Backer,et al.  Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. , 1999, The European respiratory journal.

[58]  D. Postma,et al.  The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Asthma Research Group. , 1999, American journal of respiratory and critical care medicine.

[59]  P. Enright,et al.  The Synergy of Low Lung Function and Low Body Mass Index Predicting All‐Cause Mortality Among Older Japanese‐American Men , 1997, Journal of the American Geriatrics Society.

[60]  D. Mannino,et al.  Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. , 1997, American journal of respiratory and critical care medicine.

[61]  S. Kivelä,et al.  Population ageing will lead to an increase in hospitalisation for chronic illnesses like asthma and COPD , 1997, Scandinavian journal of social medicine.

[62]  J. Wedzicha,et al.  Causes of death in patients with COPD and chronic respiratory failure. , 1997, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[63]  M. Lebowitz,et al.  Death certificate reporting of confirmed airways obstructive disease. , 1991, American journal of epidemiology.

[64]  B. Nordestgaard,et al.  Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. , 2006, American journal of respiratory and critical care medicine.

[65]  A. Buist,et al.  The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. , 2005, COPD.

[66]  T. Wilt,et al.  Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD). , 2005, Evidence report/technology assessment.

[67]  D. Patrick,et al.  Association of depression and life-sustaining treatment preferences in patients with COPD. , 2005, Chest.

[68]  Kirk R. Smith,et al.  The burden of disease from indoor air pollution in developing countries: comparison of estimates. , 2003, International journal of hygiene and environmental health.

[69]  Alan D. Lopez THE GLOBAL BURDEN OF DISEASE 1990-2020 , 2001 .

[70]  I. Romieu,et al.  Diet and obstructive lung diseases. , 2001, Epidemiologic reviews.

[71]  V. Goel,et al.  Time-series analysis of the relation between influenza virus and hospital admissions of the elderly in Ontario, Canada, for pneumonia, chronic lung disease, and congestive heart failure. , 1999, American journal of epidemiology.

[72]  W. Bailey,et al.  Strategies in preserving lung health and preventing COPD and associated diseases. The National Lung Health Education Program (NLHEP). , 1998, Chest.

[73]  S. Holgate,et al.  Do lower respiratory tract infections in early childhood cause chronic obstructive pulmonary disease? , 1995, American journal of respiratory and critical care medicine.

[74]  G. O'Connor,et al.  The relation of airways responsiveness and atopy to the development of chronic obstructive lung disease. , 1988, Epidemiologic reviews.

[75]  T. Petty Risk factors in the development of chronic obstructive pulmonary disease. , 1983, Medical Section proceedings : the ... annual Meeting of the Medical Section of the American Council of Life Insurance. American Council of Life Insurance. Medical Section. Meeting.